Table 8.
The creatine phosphokinase (CPK, U/L) levels of patients during the treatment period
| Patient No. | Baseline | Day 1 | Day 3 | Day 7 |
|---|---|---|---|---|
| High-dose group (12 mg/kg/d) | ||||
| 1 | 8 | 4 | 11 | 10 |
| 2 | 12 | 13 | 18 | 16 |
| 3 | 20 | 48 | 197 | 107 |
| 4 | 8 | 10 | 6 | 7 |
| 5 | 21 | 34 | 33 | 15 |
| 6 | 36 | 27 | 26 | 19 |
| 7 | 24 | 23 | 59 | 15 |
| Average ± SD | 18.4 ± 10.1 | 22.7 ± 15.2 | 50.0 ± 67.1 | 27.0 ± 35.5 |
| Standard-dose group (6 mg/kg/d) | ||||
| 8 | 10 | 7 | 11 | 9 |
| 9 | 9 | 16 | 19 | 16 |
| 10 | 17 | 22 | 25 | 28 |
| Average ± SD | 12.0 ± 4.4 | 15.0 ± 7.5 | 18.3 ± 7.0 | 17.7 ± 9.6 |
| P* | .330 | .439 | .262 | .675 |
*P values comparing high- and standard-dose groups.